Company profile for Tectonic Therapeutic

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs). With our proprietary GEODe™ platform, we are targeting the most difficult, previously undruggable receptors in the class, aiming to unlock their therapeutic utility to develop new treatments for a broad range of patients with i...
Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs). With our proprietary GEODe™ platform, we are targeting the most difficult, previously undruggable receptors in the class, aiming to unlock their therapeutic utility to develop new treatments for a broad range of patients with important unmet needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
490 Arsenal Way, Suite 210 Watertown, MA 02472
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/01/3196971/0/en/Tectonic-Therapeutic-to-Participate-in-December-Investor-Conferences.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/06/3183059/0/en/Tectonic-Therapeutic-Announces-Third-Quarter-2025-Financial-Results-and-Recent-Business-Highlights.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/10/29/3176829/0/en/Tectonic-Therapeutic-Announces-Positive-Topline-Data-from-Phase-1b-Part-B-Clinical-Trial-for-TX45-in-Patients-with-Group-2-Pulmonary-Hypertension-in-HFrEF.html

GLOBENEWSWIRE
29 Oct 2025

https://www.globenewswire.com/news-release/2025/08/28/3140831/0/en/Tectonic-Therapeutic-to-Participate-in-September-Investor-Conferences.html

GLOBENEWSWIRE
28 Aug 2025

https://www.globenewswire.com/news-release/2025/08/07/3129619/0/en/Tectonic-Therapeutic-Announces-Second-Quarter-2025-Financial-Results-and-Recent-Business-Highlights.html

GLOBENEWSWIRE
07 Aug 2025

https://www.globenewswire.com/news-release/2025/06/30/3107408/0/en/Tectonic-Therapeutic-Joins-Russell-3000-Index.html

GLOBENEWSWIRE
30 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty